Company

Purespring Therapeutics

Biotechnology Research Centre, United Kingdom 56 employees

Employees: 56
Contacts: 4
Emails: 4
Phones: 1

www.purespringtx.com LinkedIn Crunchbase

Purespring Therapeutics Overview

Headquarters: Centre, United Kingdom
Website: www.purespringtx.com
Industry: Biotechnology Research
Employees: 56
Founded: 2020
Funding: 104.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotechnology gene therapy kidney diseases

About Purespring Therapeutics

Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.

Purespring Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Purespring Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sachin Kelkar	Chief Financial Officer at Purespring Therapeutics	London, England, United Kingdom	Email Phone
Tony Bou Kheir	Head of Analytical Development & Qc at Purespring Therapeutics	London, England, United Kingdom	Email
Haseeb Ahmad	Chief Executive Officer at Purespring Therapeutics	London, England, United Kingdom	Email
Julian Hanak	CEO Purespring Therapeutics	London, England, United Kingdom	Email